WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 10,39 | 10,39 | 2022-03-31 |
| Linfan Zhang | 5,57 | 5,57 | 2022-03-31 |
| Nordnet Pensionsförsäkring | 4,87 | 4,87 | 2022-03-31 |
| Gunvald Berger | 1,55 | 1,55 | 2022-03-31 |
| Thomas Mellqvist | 1,52 | 1,52 | 2022-03-31 |
| Kjell Stenberg | 1,51 | 1,51 | 2022-03-31 |
| Niclas Evertsson | 1,46 | 1,46 | 2022-03-31 |
| Karl Gustav Wangel | 1,29 | 1,29 | 2022-03-31 |
| Lars-Erik Forsgårdh | 1,19 | 1,19 | 2022-03-31 |
| Claes Sjölund | 1,14 | 1,14 | 2022-03-31 |
2022-08-18 Delårsrapport 2022-Q2
2022-11-17 Delårsrapport 2022-Q3